Washington Trust Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.98K | Hold |
52
| – | – | ﹤0.01% | 493 |
|
|
2025
Q1 | $8.11K | Buy |
52
+14
| +37% | +$2.18K | ﹤0.01% | 495 |
|
|
2024
Q4 | $5.23K | Hold |
38
| – | – | ﹤0.01% | 562 |
|
|
2024
Q3 | $5.67K | Hold |
38
| – | – | ﹤0.01% | 555 |
|
|
2024
Q2 | $5.18K | Hold |
38
| – | – | ﹤0.01% | 549 |
|
|
2024
Q1 | $5.75K | Hold |
38
| – | – | ﹤0.01% | 551 |
|
|
2023
Q4 | $4.79K | Hold |
38
| – | – | ﹤0.01% | 576 |
|
|
2023
Q3 | $3.56K | Hold |
38
| – | – | ﹤0.01% | 590 |
|
|
2023
Q2 | $3.39K | Hold |
38
| – | – | ﹤0.01% | 586 |
|
|
2023
Q1 | $4.08K | Hold |
38
| – | – | ﹤0.01% | 642 |
|
|
2022
Q4 | $4.64K | Hold |
38
| – | – | ﹤0.01% | 619 |
|
|
2022
Q3 | $4K | Hold |
38
| – | – | ﹤0.01% | 739 |
|
|
2022
Q2 | $4K | Hold |
38
| – | – | ﹤0.01% | 772 |
|
|
2022
Q1 | $4K | Hold |
38
| – | – | ﹤0.01% | 840 |
|
|
2021
Q4 | $5K | Buy |
+38
| New | +$5K | ﹤0.01% | 839 |
|